{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:25:31Z","timestamp":1767828331219,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.mrgentox.2017.03.003","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T23:31:31Z","timestamp":1491521491000},"page":"17-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["TP53 mutations in p53-negative dysplastic urothelial cells from Belgian AAN patients: New evidence for aristolochic acid-induced molecular pathogenesis and carcinogenesis"],"prefix":"10.1016","volume":"818","author":[{"given":"Selda","family":"Aydin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Ambroise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Cosyns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Gala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrgentox.2017.03.003_bib0005","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0272-6386(99)70136-8","article-title":"Urothelial lesions in Chinese-herb nephropathy","volume":"33","author":"Cosyns","year":"1999","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0010","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1056\/NEJM200006083422301","article-title":"Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia Fangchi)","volume":"342","author":"Nortier","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0015","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2165\/00002018-200326010-00004","article-title":"Aristolochic acid and \u2018Chinese herbs nephropathy\u2019: a review of the evidence to date","volume":"26","author":"Cosyns","year":"2003","journal-title":"Drug Saf."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0020","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/em.21756","article-title":"Aristolochic acid nephropathy: harbinger of a global iatrogenic disease","volume":"54","author":"Grollman","year":"2013","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0025","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0140-6736(93)92984-2","article-title":"Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs","volume":"341","author":"Vanherweghem","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0030","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0140-6736(94)90964-4","article-title":"Identification of aristolochic acid in Chinese herbs","volume":"343","author":"Vanhaelen","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0035","doi-asserted-by":"publisher","first-page":"e106301","DOI":"10.1371\/journal.pone.0106301","article-title":"Unambiguous detection of multiple TP53 gene mutations in AAN-associated urothelial cancer in Belgium using laser capture microdissection","volume":"9","author":"Aydin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0040","doi-asserted-by":"publisher","first-page":"12129","DOI":"10.1073\/pnas.0701248104","article-title":"Aristolochic acid and the etiology of endemic (Balkan) nephropathy","volume":"104","author":"Grollman","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0045","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1002\/ijc.26077","article-title":"TP53 Mutational signature for aristolochic acid: an environmental carcinogen","volume":"129","author":"Moriya","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0050","doi-asserted-by":"publisher","first-page":"8241","DOI":"10.1073\/pnas.1119920109","article-title":"Aristolochic acid-associated urothelial cancer in Taiwan","volume":"109","author":"Chen","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0055","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database","volume":"28","author":"Petitjean","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0060","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/ijc.28013","article-title":"Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes","volume":"133","author":"Chen","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0065","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s002040050568","article-title":"Chinese herbs nephropathy-associated slimming regimen induces tumours in the forestomach but no onterstitial nephropathy in rats","volume":"72","author":"Cosyns","year":"1998","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0070","first-page":"116","article-title":"Endemic nephropathy: the case for chronic poisoning by aristolochia","volume":"46","author":"Hranjec","year":"2005","journal-title":"Croat. Med. J."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0075","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/ndt\/gfr291","article-title":"Aristolochic acid nephropathy: variation in presentation and prognosis","volume":"27","author":"Yang","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0080","series-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs","year":"2004"},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0085","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/ijc.24006","article-title":"TP53 mutation signature supports involvement of arisrolochic acid in the aetiology of endemic nephropathy-associated tumours","volume":"124","author":"Nedelko","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0090","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1073\/pnas.0308607101","article-title":"Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harbouring a humanized p53 gene","volume":"101","author":"Liu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0095","first-page":"67","article-title":"TP53-molecular soldier\u2019s mutations in bladder cancer in the Kashmiri population","volume":"12","author":"Nanda","year":"2011","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0100","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/carcin\/21.2.235","article-title":"Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene","volume":"21","author":"Arlt","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0105","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/carcin\/22.1.133","article-title":"Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR","volume":"22","author":"Arlt","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0110","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/carcin\/18.5.1063","article-title":"32P-post-labelling analysis of DNA adducts formed by aristolochis acid in tissues from patients with Chinese herbs nephropathy","volume":"18","author":"Bieler","year":"1997","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0115","first-page":"167","article-title":"Formation and persistence of specific purine adducts by 32P-postlabelling in target and non-target organs of rats treated with aristolochic acid I","volume":"124","author":"Fernando","year":"1993","journal-title":"IARC Sci. Publ."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0120","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1093\/carcin\/15.10.2331","article-title":"Translesional synthesis on DNA templates containing site-specifically placed deoxyadenosine and deoxyguanosine adducts formed by the plant carcinogen aristolochic acid","volume":"15","author":"Broschard","year":"1994","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0125","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/mutage\/17.4.265","article-title":"Aristolochic acid a probable human cancer hazard in herbal remedies: a review","volume":"17","author":"Arlt","year":"2002","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0130","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/nar\/gkp815","article-title":"DNA adducts of aristolochic acid II: total synthesis and site-specific mutagenesis studies in mammalian cells","volume":"38","author":"Attaluri","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0135","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1021\/tx500423m","article-title":"Comparison of DNA and RNA adduct formation: significantly higher levels of RNA than DNA modifications in the internal organs of Aristolochic acid-dosed rats","volume":"28","author":"Leung","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0140","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mrrev.2013.02.003","article-title":"Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, arictolochic acid","volume":"753","author":"Hollstein","year":"2013","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0145","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/mutage\/ger023","article-title":"Aristolochic acid-induced carcinogenesis examined by ACB-PCR quantification of H-Ras and K-Ras mutant fraction","volume":"26","author":"Wang","year":"2011","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0150","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/path.1838","article-title":"Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry","volume":"207","author":"Nenutil","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0155","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.gene.2012.02.011","article-title":"Different mutation profiles associated to P53 accumulation in colorectal cancer","volume":"499","author":"L\u00f3pez","year":"2012","journal-title":"Gene ."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0160","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/00129039-200306000-00007","article-title":"Lack of p53 nuclear immunostaining is not indicative of absence of TP53 gene mutations in colorectal adenocarcinomas","volume":"11","author":"Colomer","year":"2003","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0165","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1758-3284-2-36","article-title":"P53 in head and neck cancer: functional consequences and environmental implications of TP53 mutations","volume":"2","author":"Peltonen","year":"2010","journal-title":"Head Neck Oncol."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0170","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc2693","article-title":"When mutants gain new powers: news from the mutant p53 field","volume":"9","author":"Brosh","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0175","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1038\/sj.onc.1210294","article-title":"Transcription regulation by mutant p53","volume":"26","author":"Weisz","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0180","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/(SICI)1097-0215(19970904)72:5<739::AID-IJC6>3.0.CO;2-T","article-title":"Ras mutation and expression of the ras-regulated genes osteopontin and cathepsin L in human esophageal cancer","volume":"72","author":"Casson","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0185","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1158\/0008-5472.CAN-08-3426","article-title":"High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer","volume":"69","author":"Holstege","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0190","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/bpa.12173","article-title":"Revisiting TP53 mutations and immunohistochemistry-a comparative study in 157 diffuse gliomas","volume":"25","author":"Takami","year":"2015","journal-title":"Brain Pathol."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0195","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.urology.2003.11.031","article-title":"Clinical evaluation of p53 mutations in urothelial carcinoma by IHC and FASAY","volume":"63","author":"Watanabe","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0200","first-page":"469","article-title":"Relationship between p53 gene mutation and protein expression: clinical significance in transitional cell carcinoma of the bladder","volume":"16","author":"Gao","year":"2000","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0205","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.humpath.2010.07.007","article-title":"Bladder cancer: translating molecular genetic insights into clinical practice","volume":"42","author":"Cheng","year":"2011","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0210","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.humpath.2009.07.002","article-title":"Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features","volume":"41","author":"Hodges","year":"2010","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0215","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1383-5718(01)00188-7","article-title":"Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy","volume":"494","author":"Arlt","year":"2001","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2017.03.003_bib0220","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/TP.0000000000000941","article-title":"Long-term outcome of kidney recipients transplanted for aristolochic acid nephropathy","volume":"100","author":"Kanaan","year":"2016","journal-title":"Transplantation"}],"container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571816304454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571816304454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T15:06:55Z","timestamp":1568992015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383571816304454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":44,"alternative-id":["S1383571816304454"],"URL":"https:\/\/doi.org\/10.1016\/j.mrgentox.2017.03.003","relation":{},"ISSN":["1383-5718"],"issn-type":[{"value":"1383-5718","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TP53 mutations in p53-negative dysplastic urothelial cells from Belgian AAN patients: New evidence for aristolochic acid-induced molecular pathogenesis and carcinogenesis","name":"articletitle","label":"Article Title"},{"value":"Mutation Research\/Genetic Toxicology and Environmental Mutagenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrgentox.2017.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}